Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Шарҳ мақола

Differentiating connexin hemichannels and pannexin channels in cellular ATP release

Alexander W. LohmanDepartment of Molecular Physiology and Biophysics, University of Virginia, Charlottesville, VA 22098, United States; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, United StatesBrant E. IsaksonDepartment of Molecular Physiology and Biophysics, University of Virginia, Charlottesville, VA 22098, United States; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, United States. Electronic address: [email protected]
2014en
ABI

Аннотация

Adenosine triphosphate (ATP) plays a fundamental role in cellular communication, with its extracellular accumulation triggering purinergic signaling cascades in a diversity of cell types. While the roles for purinergic signaling in health and disease have been well established, identification and differentiation of the specific mechanisms controlling cellular ATP release is less well understood. Multiple mechanisms have been proposed to regulate ATP release with connexin (Cx) hemichannels and pannexin (Panx) channels receiving major focus. However, segregating the specific roles of Panxs and Cxs in ATP release in a plethora of physiological and pathological contexts has remained enigmatic. This multifaceted problem has arisen from the selectivity of pharmacological inhibitors for Panxs and Cxs, methodological differences in assessing Panx and Cx function and the potential compensation by other isoforms in gene silencing and genetic knockout models. Consequently, there remains a void in the current understanding of specific contributions of Panxs and Cxs in releasing ATP during homeostasis and disease. Differentiating the distinct signaling pathways that regulate these two channels will advance our current knowledge of cellular communication and aid in the development of novel rationally-designed drugs for modulation of Panx and Cx activity, respectively.

Ҳали таржима қилинмаган

Идентификаторлар

Иқтибослар ва манбалар

2 та иқтибос0 та фойдаланилган манба